Harrow (HROW) Cash from Investing Activities (2012 - 2026)

Harrow (HROW) recorded quarterly Cash from Investing Activities of -$18.2 million in Q1 2026, down 284.84% quarter-over-quarter from -$4.7 million in Q4 2025, and down 8486.32% on a YoY basis from $217055.9 in Q1 2025.

Harrow (HROW) Cash from Investing Activities (2012 - 2026) Analysis & Trends

Harrow's Cash from Investing Activities history runs 15 years deep, the most recent figure standing at -$18.2 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 8486.32% year-over-year to -$18.2 million; the TTM figure through Mar 2026 stood at -$23.5 million (up 29.5% YoY), while the FY2025 annual figure was -$5.5 million, up 83.54% from the prior year.
  • Cash from Investing Activities was -$18.2 million for Q1 2026 at Harrow, down from -$4.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $5.1 million in Q2 2024 to a low of -$131.0 million in Q1 2023.
  • Historically, Cash from Investing Activities has averaged -$12.4 million across 5 years, with a median of -$410000.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities sank 31843.9% in 2023, then jumped 508.57% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$5000.0 in 2022, then sank by 3960.0% to -$203000.0 in 2023, then plunged by 18402.46% to -$37.6 million in 2024, then jumped by 87.41% to -$4.7 million in 2025, then tumbled by 284.84% to -$18.2 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$18.2 million (Q1 2026), -$4.7 million (Q4 2025), and -$225000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Harrow 1.25 Bn 1.15 Bn 27.05 Mn -18.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.20 Mn
Mar 31, 2026 -18.20 Mn
Dec 31, 2025 -4.73 Mn
Dec 31, 2025 -4.73 Mn
Sep 30, 2025 -225,000.00
Sep 30, 2025 -225,000.00
Jun 30, 2025 -293,000.00
Jun 30, 2025 -293,000.00
Mar 31, 2025 -212,000.00
Mar 31, 2025 -212,000.00
Dec 31, 2024 -37.56 Mn
Dec 31, 2024 -37.56 Mn
Sep 30, 2024 -597,000.00
Sep 30, 2024 -597,000.00
Jun 30, 2024 5.10 Mn
Jun 30, 2024 5.10 Mn
Mar 31, 2024 -110,000.00
Mar 31, 2024 -110,000.00
Dec 31, 2023 -203,000.00
Dec 31, 2023 -203,000.00